Admission Date:  [**2191-11-21**]              Discharge Date:   [**2191-11-24**]   Service: MEDICINE  Allergies: Heparin Agents  Attending:[**First Name3 (LF) 2745**] Chief Complaint: Palpitations  Major Surgical or Invasive Procedure: None  History of Present Illness: 83 M with pmhx of afib, cva, recent dx of high grade glioma in l cerebral peduncle) was enroute to [**Hospital1 18**] for 1st session xrt, transport noted he was tachypneic, also had aspiration event.
On arrival, he did not complain of dizziness, chest pain, palpitations, nausea, vomitting.
Past Medical History: L high grade glioma (left cerebral peduncle and posterior limb of the left internal capsule) atrial fibrillation (?atrial flutter), diagnosed [**6-11**] - was on coumadin HTN Hyperlipidemia CVA, [**6-11**] (left inferior quadrantanopsia from a right medial occipital infarct) presbycusis (pt wears hearing aids) right carpal tunnel syndrome (well controlled with wrist splint worn at night) PVD with claudication for several years (followed by Dr. [**Last Name (STitle) 1391**] PEG placed [**2191-11-11**] probalance full: @ 75 cc/hr .
PSH: thyroid surgery ([**2144**]) Patient states "I had a benign growth removed" L inguinal hernia repair R rotator cuff repair  Social History: Retired proof reader as above.
Of note, if further evaluation of the known underlying mass lesions is required, an [**Month/Year (2) 4338**] with gadolinium would be recommended.
No evidence of PE, infection, ischemia, medication noncompliance, substance use/withdrawal.
Patient received IV diltiazem with resumption of his outpatient medication regimen with short-acting form of diltiazem 60 mg po qid(on diltiazem SR 240 mg po qd as outpatient) and metoprolol [**Hospital1 **] with good rate control throughout the rest of his admission.
Since hypovolemia appeared to be a trigger for the patient's a-fib with RVR and since he has poor po intake, on discharge the patient's lasix was decreased from 40 mg po qd to 20 mg po qd.
Since there was now a clear explanation for the patient's thrombocytopenia, the patient's keppra was restarted and dilantin discontinued.
Glioma-The patient received 3 treatments of brain XRT on consecutive days before discharge.
CVA- Hx of CVA-On aspirin, warfarin contraindicated due to glioma.
Speech and swallow evaluated the patient and noted that he is a silent aspiration risk and instructed that the patient not take any meds by mouth.
the patient receives his meds via G-tube.
Medications on Admission: Furosemide 40 mg Daily Atorvastatin 20 mg Daily Allopurinol 300 mg Daily Diltiazem HCl 240 mg SR Daily Valsartan 160 mg [**Hospital1 **] Metoprolol Succinate 50 mg QD Levetiracetam 1000 mg [**Hospital1 **] Pantoprazole 40 mg Tablet [**Hospital1 **] Nystatin 100,000 unit/mL Suspension [**Hospital1 **]: Five (5) ML PO QID PRN Aspirin 81 mg QD Metronidazole 500 mg TID for 6 days.
[**11-17**] Levofloxacin 500 mg QD for 6 days.
([**11-17**]) Miconazole Nitrate 2 % Powder [**Month/Year (2) **]: Topical QID PRN Fibersource 75cc.hr  Discharge Medications:  1.
Atorvastatin 20 mg Tablet [**Month/Year (2) **]: One (1) Tablet PO DAILY (Daily).
Allopurinol 300 mg Tablet [**Month/Year (2) **]: One (1) Tablet PO DAILY (Daily).
Aspirin 81 mg Tablet, Chewable [**Month/Year (2) **]: One (1) Tablet, Chewable PO DAILY (Daily).
Lansoprazole 30 mg Tablet,Rapid Dissolve, DR [**Last Name (STitle) **]: One (1) Tablet,Rapid Dissolve, DR [**Last Name (STitle) **] DAILY (Daily).
Miconazole Nitrate 2 % Powder [**Last Name (STitle) **]: One (1) Appl Topical QID (4 times a day) as needed.
Diltiazem HCl 240 mg Capsule, Sustained Release [**Last Name (STitle) **]: One (1) Capsule, Sustained Release PO once a day.
Valsartan 160 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO twice a day.
Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr [**Last Name (STitle) **]: One (1) Tablet Sustained Release 24 hr PO once a day.
Levetiracetam 1,000 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO twice a day.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Miconazole Nitrate 2 % Powder [**Last Name (STitle) **]: One (1)  Topical qid as needed.
Lasix 20 mg Tablet [**Last Name (STitle) **]: One (1) Tablet PO once a day: NEW MED DOSE, DECREASED FROM LASIX 40 mg po qd due to poor po intake and hypovolemia.
Discharge Disposition: Extended Care  Facility: [**Hospital 169**] Center  Discharge Diagnosis: Atrial Fibrillation with Rapid Ventricular Response   Discharge Condition: Vital Signs Stable   Discharge Instructions: Return to ED if short of breath, chest pain/pressure, palpitations with symptoms of discomfort.
